ArticleInternational journal of chronic obstructive pulmonary disease2025
Nonlinear Association Between Monocyte-to-HDL Ratio and Mortality in COPD: Evidence from NHANES.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) represents a leading cause of mortality worldwide, with systemic inflammation being a key pathological feature. The association between the emerging inflammatory marker monocyte to high-density lipoprotein cholesterol ratio (MHR) and the risk of all-cause mortality in COPD patients remains unclear. Methods: Data from COPD patients in the 1999-2018 NHANES database were analyzed using Cox regression models to assess the association between MHR and all-cause mortality risk. Restricted cubic spline (RCS) modeling was used to explore nonlinear associations and identify inflection points. Time-dependent ROC curves were utilized to evaluate the predictive accuracy of MHR. Subgroup and sensitivity analyses were performed to ensure the robustness of the results. Results: This study included 1768 COPD patients and observed 606 all-cause deaths during a mean follow-up of 92 months. After adjusting for confounding factors, MHR level was significantly and positively associated with all-cause mortality risk (HR = 2.10, 95% CI: 1.53-2.89). RCS analysis revealed a nonlinear relationship between MHR and all-cause mortality risk (non-linear P = 0.004). A turning point analysis indicated a threshold effect of MHR at 0.29: mortality risk increased significantly above this value (HR = 2.52, P < 0.001) and decreased significantly below it (HR = 0.02, P = 0.006). Sex-stratified analysis showed that the association between MHR and mortality risk tended to be linear in men, while it was nonlinear in women. Time-dependent ROC analysis showed AUC values for MHR at 12, 36, 72, and 120 months were 0.73, 0.79, 0.78, and 0.81, respectively. Conclusion: Elevated MHR serves as an important risk marker for all-cause mortality in COPD patients. This association exhibits nonlinear characteristics with threshold effects, suggesting that MHR has potential value in prognostic assessment of COPD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.